HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5

AIDS Research and Human Retroviruses

Volumn 25, Issue 11, 2009, Pages 1157-1164

  Zariffard, M Reza ^a   Saifuddin, Mohammed ^b   Finnegan, Alison ^a   Spear, Gregory T ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIBODY; CHEMOKINE RECEPTOR CCR5; CYCLIN T1; MESSENGER RNA; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DNA, VIRAL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV-1; HUMANS; MICE; MICE, TRANSGENIC; RECEPTORS, CCR5; TRANSGENES; VAGINA;

EID: 71949117274     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0035     Document Type: Article

References (38)

1. Simon V, Ho DD, and Abdool Karim Q: HIV=AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006;368:489-504.
2. Walker BD and Burton DR: Toward an AIDS vaccine. Science 2008;320:760-764.
3. Grant RM, Hamer D, Hope T, Johnston R, Lange J, Lederman MM, et al.: Whither or wither microbicides? Science 2008;321:532-534.
4. Wald A and Link K: Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis 2002;185:45-52.
5. Corey L, Wald A, Celum CL, and Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: A review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004;35:435-445.
6. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, and Hayes RJ: Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 2006;20:73-83.
7. Clapham PR, Blanc D, and Weiss RA: Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 1991;181:703-715.
8. Atchison RE, Gosling J, Monteclaro FS, Franci C, Digilio L, Charo IF, and Goldsmith MA: Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines. Science 1996;274:1924-1926.
9. Bieniasz PD, Grdina TA, Bogerd HP, and Cullen BR: Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J 1998;17:7056-7065.
10. Garber ME, Wei P, Kewalramani VN, Mayall TP, Herrmann CH, Rice AP, et al.: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998;12:3512-3527.
11. Mariani R, Rutter G, Harris ME, Hope TJ, Krausslich HG, and Landau NR: A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol 2000;74:3859-3870.
12. Bieniasz PD and Cullen BR: Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol 2000;74:9868-9877.
13. Zhang JX, Diehl GE, and Littman DR: Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS ONE 2008;3:e2035.
14. Michel N, Goffinet C, Ganter K, Allespach I, Kewalramani VN, Saifuddin M, et al.: Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology 2009;6:2.
15. Binley JM, Cayanan CS, Wiley C, Schulke N, Olson WC, and Burton DR: Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J Virol 2003;77:5678-5684.
16. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, and Chen IS: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987;236:819-822.
17. Kothe DL, Decker JM, Li Y, Weng Z, Bibollet-Ruche F, Zammit KP, et al.: Antigenicity and immunogenicity of HIV- 1 consensus subtype B envelope glycoproteins. Virology 2007;360:218-234.
18. Trkola A, Matthews J, Gordon C, Ketas T, and Moore JP: A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol 1999;73:8966-8974.
19. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, and Parr EL: A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 1994;70:369-380.
20. Chun TW, Justement JS, Lempicki RA, Yang J, Dennis G Jr, Hallahan CW, et al.: Gene expression and viral prodution in latently infected, resting CD4pT cells in viremic versus aviremic HIV-infected individuals. Proc Natl Acad Sci USA 2003;100:1908-1913.
21. Anzinger JJ, Mezo I, Ji X, Gabali AM, Thomas LL, and Spear GT: HIV infection of mononuclear cells is calciumdependent. Virus Res 2006;122:183-188.
22. Folks TM, Powell D, Lightfoote M, Koenig S, Fauci AS, Benn S, et al.: Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J Exp Med 1986; 164:280-290.
23. Zariffard MR, Novak RM, Lurain N, Sha BE, Graham P, and Spear GT: Induction of tumor necrosis factor-alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis. J Infect Dis 2005;191:1913-1921.
24. Pope M and Haase AT: Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 2003;9:847-852.
25. Davis CW and Doms RW: HIV transmission: Closing all the doors. J Exp Med 2004;199:1037-1040.
26. Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, et al.: Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009;458:1034-1038.
27. Tobian AA and Quinn TC: Herpes simplex virus type 2 and syphilis infections with HIV: An evolving synergy in transmission and prevention. Curr Opin HIV AIDS 2009;4:294-299.
28. Berges BK, Akkina SR, Folkvord JM, Connick E, and Akkina R: Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-=- gammac-=- (RAG-hu) mice. Virology 2008;373:342-351.
29. Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, et al.: Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008;5:e16.
30. Wege AK, Melkus MW, Denton PW, Estes JD, and Garcia JV: Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008;324:149-165.
31. Hu J, Gardner MB, and Miller CJ: Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000;74:6087-6095.
32. Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, et al.: Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: Intravaginal and oral deposition of simian=human immunodeficiency virus in macaques results in systemic infection, elimination of CD4pT cells, and AIDS. J Virol 1997;71:4016-4023.
33. Parr MB and Parr EL: Vaginal immunity in the HSV-2 mouse model. Int Rev Immunol 2003;22:43-63.
34. Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, et al.: ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: Optimal candidate for microbicide combinations. J Infect Dis 2006;194:795-803.
35. Taylor JM, Lin E, Susmarski N, Yoon M, Zago A, Ware CF, et al.: Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2007;2: 19-28. (Pubitemid 47010244)
36. Ashkar AA, Bauer S, Mitchell WJ, Vieira J, and Rosenthal KL: Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J Virol 2003; 77:8948-8956.
37. Carr DJ, Wuest T, Tomanek L, Silverman RH, and Williams BR: The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection. Immunology 2006;118:520-526.
38. Parr EL, Holliday EM, Collard MW, and Parr MB: Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy. Arch Virol 2005;150(9):1885-1902.